Burkhard Tonshoff has received research grants from Novartis, Astellas, and Chiesi, and consulting fees from Bristol-Myers Squibb, CSL Behring Biotherapies for Life, Vifor and Chiesi. The other authors declare no conflicts of interest. We acknowledge funding from the Medical Faculty of Heidelberg to Maral Baghai Arassi.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Kai
Contact Kai, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack